“Addressing Canada’s Opioid Crisis: The Case for Decriminalisation”
Canada’s opioid crisis necessitates the decriminalization of drugs to save lives and address the societal and economic consequences of addiction.
Canada’s opioid crisis necessitates the decriminalization of drugs to save lives and address the societal and economic consequences of addiction.
The ongoing Canadian opioid crisis has far-reaching effects, impacting individuals, corporations, and public health. Efforts to combat the crisis include increased accessibility to Naloxone and public education on opioid addiction. A call to unite against the crisis highlights the need for collective commitment to overcome it.
Kroger Co. reports net loss after settling a $1.4 billion opioid case, highlighting the growing responsibility of corporations in the opioid crisis.
The opioid crisis in Northern Alberta has prompted Chiefs to declare an emergency due to the severe consequences on communities and healthcare systems. Efforts are underway to combat the crisis, but more resources are needed.
Addressing the Canadian Opioid Crisis: Collaboration Needed Between Government and Industry for funding initiatives counteracting the crisis.
Quebec initiates a class action certification to hold pharmaceutical companies accountable for their role in the opioid crisis in Canada.
Naloxone kits should include both nasal spray and injection options to combat the opioid crisis, according to an expert panel. #OpioidCrisis #NaloxoneKits
Panel in Canada calls for dual naloxone distribution – both nasal spray and injection – to better address the ongoing opioid crisis.
Addressing the Canadian opioid crisis requires private donations and community resources to tackle the associated issues of homelessness, crime, and public health.
Waterloo Region witnesses a sharp rise in opioid overdoses, highlighting the urgency of addressing the ongoing opioid crisis in Canada.